Strain Information | |
---|---|
Image | |
BRC No. | RBRC05444 |
Type | Targeted Mutation![]() |
Species | Mus musculus |
Strain name | B6;B6CB-Sec23ip<tm1.1Katn> |
Former Common name | B6-Sec23ip KO |
H-2 Haplotype | |
ES Cell line | TT2 [(C57BL/6NCrlj x CBA/JNCrlj)F1] |
Background strain | |
Appearance | |
Strain development | Developed by Katsuko Tani, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences in 2008. Targeted construct was electroporated into TT2 ES cells. Exon1 of Sec23ip gene was removed by crossing with CAG-Cre (B6) mice. |
Strain description | Sec23ip, Sec23 interacting protein (p125) knockout mice. Exon 1 of Sec23ip was deleted. Homozygous mutant male show reduced fertility. Sec23ip floxed mice (RBRC05443 B6;B6CB-Sec23ip<tm1.1Katn>) |
Colony maintenance | Heterozygote x Wild-type [C57BL/6JJcl] |
References | p125/Sec23-interacting protein (Sec23ip) is required for spermiogenesis. Arimitsu N, Kogure T, Baba T, Nakao K, Hamamoto H, Sekimizu K, Yamamoto A, Nakanishi H, Taguchi R, Tagaya M, Tani K FEBS Lett., 585, 2171-2176 (2011). 21640725 |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |||||||
---|---|---|---|---|---|---|---|
Gene Symbol | Gene Name | Chr. | Allele Symbol | Allele Name | Common Names | Promoter | Diseases Related to This Gene |
Sec23ip MGI:2450915 | Sec23 interacting protein | 7 | Sec23ip<tm1.1Katn> MGI:5085903 | targeted mutation 1.1, Katsuko Tani | |||
loxP | phage P1 loxP | 7 | loxP |
Phenotype | |
---|---|
Annotation by Mammalian phenotyhpe ontology | |
Detailed phenotype data |
Ordering Information | |
---|---|
Donor DNA | P1 Phage loxP site, mouse Sec23ip genomic DNA |
Research application | Cre/loxP system |
Specific Term and Conditions | Prior to requesting the BIOLOGICAL RESOURCE, the RECIPIENT must obtain approval from the DEPOSITOR using the Approval Form. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. FEBS Lett., 585(14): 2171-6 (2011).The RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. Within a period of TWO years after the first paper concerning of the BIOLOGICAL RESOURCE is published, the RECIPIENT agrees to use this BIOLOGICAL RESOURCE as a collaboration with the DEPOSITOR. |
Depositor | Katsuko Tani (Tokyo University of Pharmacy and Life Sciences) |
Strain Status | ![]() ![]() |
Strain Availability | Recovered litters from cryopreserved embryos (2 to 4 months) Cryopreserved sperm (within 1 month) |
Additional Info. | Necessary documents for ordering:
Genotyping protocol -PCR- |
BRC mice in Publications |
---|
No Data |